Business Context and Reporting Period
Company: HAPC, Inc. (formerly Healthcare Acquisition Partners Corp.), a Delaware corporation operating as a blank check company (SPAC) in the development stage.
Reporting Period: Quarterly period ended June 30, 2007.
Primary Objective: To acquire one or more operating businesses, primarily in the healthcare sector. The Company has entered into a definitive Stock Purchase Agreement to acquire InfuSystem, Inc. (a subsidiary of I-Flow Corporation) for a total consideration of $140,000,000.
Operational Status: The Company has not yet consummated the business combination. It is currently in the pre-acquisition phase, utilizing funds from its April 2006 IPO to finance the transaction and cover operating expenses.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2007 | Six Months Ended June 30, 2006 |
|---|---|---|
| Revenues | $0 | $0 |
| Net Income (Loss) | $(423,110) | $5,891,803 |
| Operating Expenses | $1,950,379 | $4,559,970 |
| Interest Income | $2,324,050 | $857,032 |
| Cash and Cash Equivalents (End of Period) | $99,813 | $997,268 |
| Investments Held in Trust | $100,261,456 | $98,151,128 |
| Total Current Liabilities | $16,931,810 | $15,531,640 |
| Warrant Liabilities | $9,112,636 | $9,112,636 |
| Stockholders' Equity | $65,840,115 | $65,145,780 |
Material Changes vs. Prior Period
- Net Loss vs. Net Income: The Company reported a net loss of $423,110 for the six months ended June 30, 2007, compared to a net income of $5,891,803 in the same period in 2006. The 2006 income was significantly driven by a non-cash gain of $9,787,645 on warrant liabilities, whereas the 2007 period saw no such gain.
- Operating Expenses: Total operating expenses decreased to $1,950,379 in 2007 from $4,559,970 in 2006. This reduction is primarily due to lower stock-based compensation amortization ($1,226,200 in 2007 vs. $4,381,517 in 2006) resulting from the vesting schedule.
- Liquidity: Cash and cash equivalents outside the trust account decreased significantly from $427,372 at December 31, 2006, to $99,813 at June 30, 2007. This decline is attributed to the payment of acquisition-related costs, legal fees, and professional expenses.
- Trust Account Growth: Investments held in trust increased to $100,261,456, reflecting interest income earned on the funds deposited from the IPO.
- New Liabilities: The Company incurred a "ticking fee" of $352,083 related to the InfuSystem acquisition agreement, a cost not present in the prior year.
Outlook, Risks, and Management Commentary
- Acquisition Status: The Company is actively pursuing the acquisition of InfuSystem, Inc. The termination date for the Stock Purchase Agreement has been extended multiple times, most recently to October 1, 2007. The transaction requires stockholder approval.
- Liquidity and Capital Resources: The Company has exhausted the net proceeds held outside the trust account. It is currently financing operations through the sale of warrants (e.g., $313,000 raised in April 2007). Management believes funds in the trust account are sufficient to complete the acquisition.
- Liquidation Risk: If the business combination is not consummated by April 18, 2008 (24 months from IPO), the Company will be required to liquidate and distribute trust proceeds to stockholders. The estimated per-share liquidation price as of June 30, 2007, was $5.94, subject to taxes and potential creditor claims.
- Internal Control Weakness: Management identified a material weakness in internal controls over financial reporting related to the evaluation of complex transactions and the application of GAAP, specifically regarding the accounting for warrant liabilities. Remedial actions are underway.
- Contingencies: The Company has agreed to pay a break-up fee to I-Flow if the transaction is terminated under certain conditions. This fee is guaranteed by the Company's Chairman and another director, backed by a $3,000,000 letter of credit.
Investor Verification Checklist
- Acquisition Timeline: Verify the current status of the InfuSystem acquisition and whether the October 1, 2007, termination date has been met or extended.
- Stockholder Approval: Confirm the results of the stockholder vote required to approve the business combination and the percentage of shares exercising conversion rights.
- Warrant Liability Volatility: Monitor the fair value of the $9.1 million warrant liability, as fluctuations in the market price of warrants directly impact reported net income/loss.
- Working Capital: Assess the Company's ability to fund ongoing operations and transaction costs given the low cash balance ($99,813) outside the trust account.
- Internal Controls: Review subsequent filings to confirm the remediation of the material weakness in financial reporting controls.